180 related articles for article (PubMed ID: 8821739)
41. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons.
Doucet MV; O'Toole E; Connor T; Harkin A
Neuroscience; 2015 Aug; 301():421-38. PubMed ID: 26071957
[TBL] [Abstract][Full Text] [Related]
42. Contribution of endogenous glycine site NMDA agonists to excitotoxic retinal damage in vivo.
Hama Y; Katsuki H; Tochikawa Y; Suminaka C; Kume T; Akaike A
Neurosci Res; 2006 Nov; 56(3):279-85. PubMed ID: 16934894
[TBL] [Abstract][Full Text] [Related]
43. S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity.
Ningaraj NS; Chen W; Schloss JV; Faiman MD; Wu JY
J Biomed Sci; 2001; 8(1):104-13. PubMed ID: 11173983
[TBL] [Abstract][Full Text] [Related]
44. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
Pearlstein RD; Beirne JP; Massey GW; Warner DS
J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
[TBL] [Abstract][Full Text] [Related]
46. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
[TBL] [Abstract][Full Text] [Related]
47. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
Coffin V; Cohen-Williams M; Barnett A
Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
[TBL] [Abstract][Full Text] [Related]
48. Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex.
Yang J; Wetterstrand C; Jones RS
Epilepsy Res; 2007 Dec; 77(2-3):157-64. PubMed ID: 17980555
[TBL] [Abstract][Full Text] [Related]
49. Endogenous D-serine is involved in induction of neuronal death by N-methyl-D-aspartate and simulated ischemia in rat cerebrocortical slices.
Katsuki H; Nonaka M; Shirakawa H; Kume T; Akaike A
J Pharmacol Exp Ther; 2004 Nov; 311(2):836-44. PubMed ID: 15240826
[TBL] [Abstract][Full Text] [Related]
50. Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.
Kretschmer BD
Neurosci Lett; 1994 Sep; 179(1-2):115-8. PubMed ID: 7845605
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.
Akasofu S; Kimura M; Kosasa T; Ogura H; Sawada K
Eur J Pharmacol; 2006 Jan; 530(3):215-22. PubMed ID: 16406045
[TBL] [Abstract][Full Text] [Related]
52. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
[TBL] [Abstract][Full Text] [Related]
53. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
Swartz KJ; Koroshetz WJ; Rees AH; Huettner JE
Mol Pharmacol; 1992 Jun; 41(6):1130-41. PubMed ID: 1352036
[TBL] [Abstract][Full Text] [Related]
54. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
Molnár P; Erdõ SL
Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614
[TBL] [Abstract][Full Text] [Related]
56. Characterization of neuroprotection from excitotoxicity by moderate and profound hypothermia in cultured cortical neurons unmasks a temperature-insensitive component of glutamate neurotoxicity.
Tymianski M; Sattler R; Zabramski JM; Spetzler RF
J Cereb Blood Flow Metab; 1998 Aug; 18(8):848-67. PubMed ID: 9701346
[TBL] [Abstract][Full Text] [Related]
57. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
Fatokun AA; Smith RA; Stone TW
Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
[TBL] [Abstract][Full Text] [Related]
58. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor.
Lipton SA; Kim WK; Choi YB; Kumar S; D'Emilia DM; Rayudu PV; Arnelle DR; Stamler JS
Proc Natl Acad Sci U S A; 1997 May; 94(11):5923-8. PubMed ID: 9159176
[TBL] [Abstract][Full Text] [Related]
59. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
Sofia RD; Gordon R; Gels M; Diamantis W
Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
[TBL] [Abstract][Full Text] [Related]
60. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
